Biotechnology

Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Mar 30, 2023, 16:51 ET Neptune Reports Fiscal Third Quarter Ended December 31, 2022 Financial Results

YTD net sales $40.5 million, up 8.6% from prior year Q3 net sales $12.2 million, down $2.5 million from last year, $3.5 million of decrease...

Mar 30, 2023, 15:00 ET Bridging the GAP: MaRS launches new Growth Acceleration Program

Supporting Canadian ventures building toward $20 million in revenue TORONTO, March 30, 2023 /CNW/ - MaRS today announced the launch of the Growth...

Mar 30, 2023, 11:28 ET Neptune to Report Fiscal Third Quarter 2023 Financial Results on March 30, 2023

Company to host a conference call at 5:00 p.m. (Eastern Time) LAVAL, QC, March 30, 2023 /CNW/ - Neptune Wellness Solutions Inc. ("Neptune" or the...

Mar 30, 2023, 09:05 ET DISCOVERY LIFE SCIENCES INSTALLS WORLD'S LARGEST COMMERCIAL FLEET OF NOVASEQ X PLUS SYSTEMS TO ACCELERATE GENOMIC RESEARCH WITH UNPRECEDENTED SPEED AND COST EFFICIENCY

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial...

Mar 30, 2023, 04:02 ET PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN

Piramal Pharma Solutions, a patient-centric Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd (PPL), (NSE:...

Mar 30, 2023, 00:00 ET 2023 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-RENOWNED SCIENTISTS FOR TRANSFORMATIVE CONTRIBUTIONS TO RESEARCH IMPACTING HUMAN HEALTH

TORONTO, March 30, 2023 /CNW/ - The Gairdner Foundation is pleased to announce the 2023 Canada Gairdner Award laureates, recognizing some of the...

Mar 29, 2023, 09:17 ET Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Mar 29, 2023, 09:00 ET FACIT generates $1.5 billion in follow-on investment

A commercialization landmark for Ontario cancer innovations and patient impact TORONTO, March 29, 2023 /CNW/ - FACIT announced $1.5 billion in...

Mar 28, 2023, 17:30 ET Pond Technologies Announces Non-Brokered Private Placement Including Insider Participation and Granting of Restrictive Share Units

MARKHAM, ON, March 28, 2023 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSXV: POND) (OTCQB: PNDHF) (FSE: 400), an ESG company addressing global ...

Mar 28, 2023, 16:10 ET WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT

Willow Continues its Transition to the Bay Area in California with Management Promotions and a New Board Member MOUNTAIN VIEW, Calif. , March 28,...

Mar 28, 2023, 09:20 ET BIMINI HEALTH TECH ACQUIRES EXCLUSIVE LICENSE TO ACELLULAR DERMAL MATRIX PRODUCT PORTFOLIO

Bimini Health Tech announced today it has acquired the exclusive rights to an Acellular Dermal Matrix ("ADM") technology for the plastic and...

Mar 28, 2023, 08:22 ET SQI to Focus on Development of Point of Care Products In Respiratory Health

TORONTO, March 28, 2023 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health,...

Mar 28, 2023, 07:00 ET Oncolytics Biotech® to Participate in a Panel Presentation at Cantor Fitzgerald's The Future of Oncology Virtual Symposium

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Dr. Matt Coffey, President and Chief Executive Officer, will participate in...

Mar 28, 2023, 07:00 ET Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Mar 28, 2023, 07:00 ET Seegene declares to share Syndromic PCR technologies to prevent future pandemics

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, declared the commencement of...

Mar 28, 2023, 06:00 ET Salipro Biotech publishes research in Scientific Reports on structure-function studies for membrane proteins in collaboration with AstraZeneca

Salipro Biotech today announces the publication of results from a collaboration with AstraZeneca. The study describes a novel method to directly...

Mar 28, 2023, 05:30 ET WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its...

Mar 28, 2023, 01:00 ET Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that Tavneos® has been included in the revised EULAR AAV management...

Mar 27, 2023, 10:17 ET Cora Therapeutics Announces $1M In Seed Funding

TORONTO, March 27, 2023 /CNW/ - Cora Therapeutics, a Toronto based life sciences start up, is pleased to announce the company has raised $1M in Seed...

Mar 27, 2023, 08:00 ET PROPOSED DISPOSITION OF COMMON SHARES AND EXERCISE OF WARRANTS OF SQI DIAGNOSTICS INC.

/NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICES./ CALGARY, AB, March 27, 2023 /CNW/ - Mr. Clive J. Beddoe ("Mr....

Mar 27, 2023, 07:30 ET Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination

Registration now open: A case by case review of innovative and practical solutions for preventing CLABSI MISSISSAUGA, ON, March 27, 2023 /CNW/ -...

Mar 24, 2023, 14:30 ET Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the US Food and Drug Administration (FDA)...

Mar 24, 2023, 13:05 ET Health Canada approves first treatment option for generalized pustular psoriasis flares in adults

- Generalized pustular psoriasis differs significantly from plaque psoriasis in both its disease mechanism and severity.1 - In the EFFISAYIL®-1...

Mar 24, 2023, 08:21 ET SQI DIAGNOSTICS ANNOUNCES PROPOSED INSIDER SALES AND WARRANT EXERCISES TO FUND COMPANY

TORONTO, March 24, 2023 /CNW/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that ...

Mar 23, 2023, 17:00 ET Eupraxia Pharmaceuticals Reports Fourth Quarter and 2022 Financial Results

VICTORIA, BC, March 23, 2023 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology...